COMP <GO>
SMTI vs ENOV // 10Y YIELD & FRED MACRO BETA
Sanara MedTech Inc. (NASDAQ) VS. Enovis Corporation (NYSE) • 15-METRIC TALLY: SMTI 6
— ENOV 3
■ METRIC PARITY
LAST: $32.07 (-2.31%) • MKT CAP: $301.6M
macro-sensitivity
—
LAST: $20.62 (+3.57%) • MKT CAP: $1.15B
macro-sensitivity
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SMTI VS. ENOV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SMTI | ENOV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 92.70% | 59.80% | +32.90 | SMTI | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 16.30% | -32.70% | +49.00 | SMTI | /roic <GO> |
| EV/EBITDA & P/E Valuation | 29.5x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 0.71% | 1.51% | -0.80 | ENOV | /fcf-yield <GO> |
| Operating Margin | 7.10% | -50.00% | +57.10 | SMTI | /operating-margins <GO> |
| Net Profit Margin | 36.40% | -52.70% | +89.10 | SMTI | /net-margins <GO> |
| Revenue Growth (YoY) | 19.00% | 6.70% | +12.30 | SMTI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.25 | 0.20 | +3.05 | SMTI | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 29.1 | 48.2 | -19.10 | ENOV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 6.8x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $301.6M | $1.15B | -$846.6M | ENOV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SMTI REV | ENOV REV | SMTI GROSS % | ENOV GROSS % | SMTI FCF | ENOV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $103.1M | $2.25B | 92.7% | 59.8% | $2.2M | $19.9M |
| FY 2024 | $86.7M | $2.11B | 90.6% | 56.0% | -$229.6K | -$67.2M |
| FY 2023 | $65.0M | $1.71B | — | — | -$3.2M | $135.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SMTI // BETA —
ENOV // BETA —